Benitec Biopharma Inc. (BNTC) Balance Sheet
As of 2026-06-30 (10-K), Benitec Biopharma Inc. (BNTC) reported total assets of $182.6M, total liabilities of $5.6M and shareholders' equity of $177.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $180.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BNTCBenitec Biopharma Inc.Follow BNTC — free
—
Price chart with a free account
- Market cap
- 301.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
| Line | FY2019 Jun 19 | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15.7 | 9.8 | 19.8 | 4.1 | 2.5 | 50.9 | 97.7 | 180.0 | 180.0 | |
| Receivables | 2.5 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Current assets | 18.8 | 10.8 | 20.6 | 4.8 | 3.7 | 51.7 | 98.5 | 181.7 | 181.7 | |
| Total assets | 19.2 | 11.6 | 21.4 | 6.0 | 4.5 | 52.2 | 99.6 | 182.6 | 182.6 | |
| Current liabilities | 2.6 | 1.1 | 1.4 | 2.5 | 4.0 | 4.9 | 1.8 | 5.3 | 5.3 | |
| Total liabilities | 2.6 | 1.3 | 1.4 | 3.1 | 4.3 | 5.0 | 2.3 | 5.6 | 5.6 | |
| Shareholders' equity | 16.6 | 10.2 | 20.0 | 2.9 | 0.2 | 47.2 | 97.3 | 177.0 | 177.0 |
USD millions · SEC XBRL
Benitec Biopharma Inc. — questions
- How much cash does Benitec Biopharma Inc. have?
- $180.0M in cash and cash equivalents as of 2026-06-30.
- What are Benitec Biopharma Inc.'s total assets?
- $182.6M as of 2026-06-30.
- What is Benitec Biopharma Inc.'s shareholders' equity?
- $177.0M as of 2026-06-30.
Every figure on this page comes from Benitec Biopharma Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.